June 01, 2007
DDMAC says Ciprodex sales aid omits facts
The FDA’s DDMAC says a retail sell sheet and sales aid for Alcon Laboratories’ Ciprodex omits material facts about the drug, including some risk information and limits to its indication.
The government agency released its latest guidance this week.
11 questions for the GW CEO on the watershed moment.
The Office of Prescription Drug Promotion has sent its second warning letter of the year.